These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24798832)

  • 21. [Current anti-inflammatory therapy in patients with chronic obstructive pulmonary disease].
    Shmelev EI; Shmeleva NM
    Ter Arkh; 2012; 84(6):73-6. PubMed ID: 22997924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD; Dai YR; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternatives to indicating roflumilast and the chronic obstructive pulmonary disease classification.
    Blasco LM
    Arch Bronconeumol; 2012 Sep; 48(9):343. PubMed ID: 22503591
    [No Abstract]   [Full Text] [Related]  

  • 24. The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.
    Cazzola M
    Ther Adv Respir Dis; 2010 Aug; 4(4):195-8. PubMed ID: 20696819
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease.
    Wedzicha JA
    Pol Arch Med Wewn; 2010; 120(1-2):9-10. PubMed ID: 20150838
    [No Abstract]   [Full Text] [Related]  

  • 26. Choice of bronchodilator therapy for patients with COPD.
    Wedzicha JA
    N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773
    [No Abstract]   [Full Text] [Related]  

  • 27. A review of the advances in chronic obstructive pulmonary disease treatment.
    Metzger NL; Lundquist LM
    J Pharm Pract; 2012 Dec; 25(6):576-82. PubMed ID: 23076966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do we need three players in COPD treatment?
    Maestrelli P; Mason P; Costa F; Paggiaro P
    Respiration; 2013; 86(4):275-6. PubMed ID: 23988429
    [No Abstract]   [Full Text] [Related]  

  • 29. Triple inhaler therapy for COPD.
    Lipworth B
    Thorax; 2015 Oct; 70(10):991. PubMed ID: 26092923
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phosphodiesterase-4 inhibitors: a new target in treatment of COPD].
    Michels G; Erdmann E; Pfister R
    Dtsch Med Wochenschr; 2011 Nov; 136(44):2267-70. PubMed ID: 22028292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiotropium versus salmeterol in COPD.
    Lloret-Linares C; Bergmann JF
    N Engl J Med; 2011 Jun; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656
    [No Abstract]   [Full Text] [Related]  

  • 32. Roflumilast for severe COPD?
    Drug Ther Bull; 2011 Apr; 49(4):45-8; quiz iii-iv. PubMed ID: 21467576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen A
    Am J Respir Crit Care Med; 2008 Jul; 178(1):105; author reply 106-7. PubMed ID: 18565963
    [No Abstract]   [Full Text] [Related]  

  • 34. Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
    Page CP
    Int Arch Allergy Immunol; 2014; 165(3):152-64. PubMed ID: 25532037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiotropium versus salmeterol in COPD.
    Schembri S
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
    [No Abstract]   [Full Text] [Related]  

  • 36. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

  • 37. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Puhan M
    Cochrane Database Syst Rev; 2011 May; 2011(8):ED000028. PubMed ID: 21833986
    [No Abstract]   [Full Text] [Related]  

  • 38. Dual anti-inflammatory agents prevent COPD exacerbations.
    Tashkin DP
    Lancet; 2015 Mar; 385(9971):832-4. PubMed ID: 25684589
    [No Abstract]   [Full Text] [Related]  

  • 39. Roflumilast Altana Pharma.
    Reid P
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1165-70. PubMed ID: 12211409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COPD: improving prevention and care.
    Lancet; 2015 Mar; 385(9971):830. PubMed ID: 25773073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.